Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194439 · ClinicalTrials.gov registry record
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 415
- Enrollment target
NCT02194439: Completed study, sponsored by Indiana University.
NCT02194439 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 415 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02194439 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 415 participants
- Enrollment target
Study Summary
This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers include Dana-Farber Cancer Institute and Boston's Children's Hospital, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center, Texas Children's Hospital, Children's National Medical Center, and Indiana University Simon Cancer Center.
Primary Outcome
To measure stimulation-2 (ST2) pre-HCT by number of participants at 12 months post-HCT for non-relapse mortality according to ST2 values and age less than or equal to 10 and greater than 10 using landmark analyses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-09-30 |
What the finished NCT02194439 record still lists
NCT02194439 is an observational study that tracks outcomes without assigning an intervention. The registered 415 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02194439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02194439 about?
NCT02194439 is a clinical study titled "Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease". This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers inc...
What is the current status of trial NCT02194439?
This trial is currently completed. The enrollment target is 415 participants. The study started on 2014-01. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT02194439?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia